Amphastar Pharmaceuticals Inc (AMPH) Q4 2025 Earnings Call Transcript
Amphastar Pharmaceuticals reported full‑year 2025 net revenues of $719.9 million, a modest 2% decline, while its flagship product Baqsimi grew 12% to $185.4 million. The company secured FDA approval for ipratropium bromide HFA (AMP‑007), gaining 180‑day generic exclusivity, and announced a major expansion of its Rancho Cucamonga manufacturing site. Operating cash flow reached $156.1 million, supporting increased R&D, capital spending, and a continued share‑buyback program. Management guided 2026 revenue growth in the mid‑ to high‑single‑digit range, acknowledging margin pressure from legacy product pricing and higher input costs.
Kimbell Royalty Partners LP (KRP) Q4 2025 Earnings Call Transcript
Kimbell Royalty Partners reported Q4 2025 production of 25,627 BOE per day and adjusted EBITDA of $64.8 million, while proved reserves rose 8% to a record 73 million BOE. The company declared a $0.37 per unit distribution, a 6% increase, classified entirely as return of...
Charter’s Video Sub Gains Fuel Earnings Optimism
Charter Communications reported its first quarterly video subscriber increase since 2020, adding roughly 44,000 net video customers in Q4 2025. The gain sparked optimism on earnings calls at Nexstar, Sinclair and AMC Networks, which highlighted the role of bundled over‑the‑top...
D-Wave Quantum Inc (QBTS) Q4 2025 Earnings Call Transcript
D‑Wave Quantum reported fiscal 2025 revenue of $24.6 million, up 179% year‑over‑year, driven by $16.2 million in system sales and $5.5 million in QCaaS subscriptions. Bookings jumped 471% in Q4 to $13.4 million after a €10 million multiyear contract, while the sales pipeline expanded nearly...
Pacira Biosciences Inc (PCRX) Q4 2025 Earnings Call Transcript
Pacira BioSciences reported a record $726 million in total 2025 revenue and an all‑time high non‑GAAP gross margin of 80%, driven by growth in its flagship product EXPAREL. EXPAREL sales rose 7% year‑over‑year to $155.8 million, though the increase was partially offset...
Where Food Comes From Inc (WFCF) Q4 2025 Earnings Call Transcript
Where Food Comes From Inc. posted a modest revenue dip to $7 million in the quarter, down $92,000 year‑over‑year, but net income more than doubled to $1.1 million thanks largely to a $946,000 gain from the Progressive Beef sale. Verification and certification...
Goldman Sachs BDC Inc (GSBD) Q4 2025 Earnings Call Transcript
Goldman Sachs reported a 27% rise in annual earnings per share to $51.32, driven by record $41.5 billion global banking revenue and strong performance across investment banking, FICC, equities, and asset‑wealth management. Return metrics improved, with quarterly ROE at 16% and...
DENTSPLY SIRONA Inc (XRAY) Q4 2025 Earnings Call Transcript
Dentsply Sirona reported Q4 2025 revenue of $961 million, a 6.2% reported increase and 2.5% constant‑currency growth, while adjusted EBITDA margin slipped to 14.1%. The company recorded a $144 million non‑cash goodwill impairment and discontinued its $128 million annual dividend to prioritize debt...
Monster Beverage Corp (MNST) Q4 2025 Earnings Call Transcript
Monster Beverage reported record fourth‑quarter net sales of $1.81 billion, a 4.7% year‑over‑year increase and 7.8% on a currency‑neutral basis. Gross profit margin rose to 55.3% (55.5% excluding alcohol‑brand inventory reserves), while operating income fell 12.2% to $381.2 million due to a...
Teleflex Inc (TFX) Q4 2025 Earnings Call Transcript
Teleflex reported 2025 adjusted EPS of $6.98, an 8.7% increase, while outlining a $2.03 billion divestiture plan that will net roughly $1.8 billion after tax. Management pledged to allocate $1 billion to share repurchases and use the remaining $800 million to reduce debt, bolstering...
Alpha Teknova Inc (TKNO) Q4 2025 Earnings Call Transcript
Alpha Teknova reported Q4 2025 revenue of $10.5 million, a 9% year‑over‑year increase and the fifth consecutive quarter of growth, driven primarily by its Lab Essentials catalog line. Lab Essentials revenue rose 16% to $8.3 million, while Clinical Solutions revenue slipped 13%...
Ecovyst Inc (ECVT) Q4 2025 Earnings Call Transcript
Ecovyst reported Q2 2025 Ecoservices sales of $176 million, a 14% year‑over‑year increase driven by higher sulfur pass‑throughs and the newly acquired Wagaman site. Adjusted EBITDA reached just under $56 million, surpassing the top end of its non‑GAAP guidance. The company closed...
Tactical Agreement Proving Elusive for Central Asian States Grappling with Water Deficit
Central Asian states recognize an urgent water shortage as they pursue water‑intensive projects like nuclear plants, data centers and expanded mining. Upstream nations Kyrgyzstan and Tajikistan control most supplies, while downstream Kazakhstan, Turkmenistan and Uzbekistan depend on irrigation, creating a...
Sempra (SRE) Q4 2025 Earnings Call Transcript
Sempra reported adjusted Q3 2025 EPS of $1.11, a 25% year‑over‑year rise, while GAAP earnings fell to $0.12 per share because of a $514 million non‑recurring tax charge. The company reaffirmed its 2025‑2026 adjusted EPS guidance and highlighted a $10 billion sale...
Purecycle Technologies Inc (PCT) Q4 2025 Earnings Call Transcript
PureCycle Technologies reported Q4 2025 revenue of $2.7 million, marking a fourth consecutive quarter of sequential growth, while achieving record production at its Denver (14 million lb processed) and Ironton (7.5 million lb produced) facilities. The company reduced feedstock procurement costs by $0.06 per pound,...
Talen Energy Corp (TLN) Q4 2025 Earnings Call Transcript
Talen Energy reported adjusted EBITDA of $1.035 billion and adjusted free cash flow of $524 million for 2025, with Q4 cash flow surpassing the entire 2024 level. The company reaffirmed its 2026 guidance, targeting $1.75‑$2.05 billion EBITDA and $980‑$1.18 billion free cash flow, while...
PubMatic Inc (PUBM) Q4 2025 Earnings Call Transcript
PubMatic reported a 9% year‑over‑year revenue increase for 2024, with underlying Q4 growth of 16% after excluding a DSP‑related headwind and political ad boost. CTV surged to 20% of quarterly revenue, more than doubling its share, while adjusted EBITDA margin...
Privia Health Group Inc (PRVA) Q4 2025 Earnings Call Transcript
Privia Health reported a robust 2025, with implemented providers rising 12.3% to 5,380 and attributed lives increasing 22.7% to 1.54 million. Practice collections grew 16.9% to $3.47 billion and adjusted EBITDA surged 38.8% to $125.5 million, delivering a 130% free‑cash‑flow conversion. The company...
International Seaways Inc (INSW) Q4 2025 Earnings Call Transcript
International Seaways reported Q3 2025 net income of $71 million ($1.42 per share) and adjusted EBITDA of $108 million, while generating roughly $63 million of free cash flow. The company ended the quarter with $985 million of total liquidity, a cash balance of $413 million...
Compass Inc (COMP) Q4 2025 Earnings Call Transcript
Compass reported a 25.9% year‑over‑year revenue increase in Q4 2024 and generated $16.7 million of adjusted EBITDA, rising to $20.9 million when excluding Christie's acquisition costs. The broker added 669 principal agents in the quarter, boosting its net principal agent count by...
ACM Research Inc (ACMR) Q4 2025 Earnings Call Transcript
Amkor Technology reported Q4 2025 revenue of $1.89 billion, up 16% year‑over‑year, and EPS of $0.69, beating the top end of guidance. Full‑year revenue reached $6.7 billion, a 6% increase, with advanced packaging revenue setting a new record after a 7% rise....
Akebia Therapeutics Inc (AKBA) Q4 2025 Earnings Call Transcript
Akebia Therapeutics reported 2025 total revenue of $236.2 million, a 47% increase driven by the commercial launch of Vafseo and higher Auryxia sales. Net product revenue reached $227 million, with Vafseo contributing $45.8 million and gaining prescribing access for 290,000 dialysis patients. The...
MidCap Financial Investment Corp (MFIC) Q4 2025 Earnings Call Transcript
MidCap Financial Investment Corp reported Q4 2025 GAAP net income of $54.3 million ($0.42 per share) and distributable earnings of $27.8 million ($0.27 per share). The REIT acquired $1.9 billion of loans and securities, expanding its Agency MBS portfolio by over 50% and...
Hudson Pacific Properties Inc (HPP) Q4 2025 Earnings Call Transcript
Hudson Pacific Properties reported a transformative 2025, completing roughly $330 million of strategic asset sales and over $2 billion of capital transactions that doubled its liquidity to $934 million. The REIT reduced net debt by 22%, improved its debt‑to‑book ratio to 31.9%, and...
OPKO Health Inc (OPK) Q4 2025 Earnings Call Transcript
OPKO Health reported a $369 million cash position for Q4 2025, driven by asset sales, BARDA funding and partnership payments. The company repurchased 34.6 million shares for $47 million and allocated $109 million to stock and convertible note buybacks. Diagnostics revenue dropped to $71.1 million, but...
ICF International Inc (ICFI) Q4 2025 Earnings Call Transcript
ICF International reported Q3 2025 revenue of $465.4 million, a 10% YoY decline driven primarily by a 29.8% drop in federal contract earnings amid a government shutdown. Non‑federal segments, especially commercial energy, offset some weakness, posting 24% revenue growth and...
MSC Income Fund Inc (MSIF) Q4 2025 Earnings Call Transcript
MSCI Inc. reported double‑digit organic revenue growth of over 10% in Q4 2025, accompanied by adjusted EBITDA up more than 13% and adjusted EPS rising nearly 12% quarter‑over‑quarter. The company’s subscription run rate topped $3.3 billion, driven by an 18% surge...
Austin Gold Corp (AUST) Q4 2025 Earnings Call Transcript
Royal Gold reported record 2025 results, with annual revenue of $1 billion, a 43% increase, and operating cash flow of $705 million, up 33%. Net income rose 40% to $466 million, while adjusted net income hit $510 million, boosted by strong gold prices and...
Koppers Holdings Inc (KOP) Q4 2025 Earnings Call Transcript
Koppers Holdings reported third‑quarter 2025 sales of $485 million, a 12% decline year‑over‑year, as volume drops hit all three segments. Adjusted EBITDA fell to $70.9 million, but margin remained solid at 14.6% thanks to aggressive SG&A reductions and the Catalyst cost‑saving program....
Elastic NV (ESTC) Q3 2026 Earnings Call Transcript
Elastic N.V. reported Q3 fiscal 2026 revenue of $450 million, up 18% year‑over‑year, and a non‑GAAP operating margin of 18.6%. The company’s current remaining performance obligations (CRPO) surpassed $1 billion for the first time, indicating strong forward visibility. AI‑related usage expanded,...
CABO At Our Deadline
Cable One reported a Q4 2025 decline of 10,700 residential data subscriptions and revenue falling to $363.7 million, down from $387.2 million a year earlier. CFO Todd Koetje noted modest improvements in disconnect rates but said they remain unsatisfactory. The...
Qnity Electronics Inc (Q) Q4 2025 Earnings Call Transcript
Sequans Communications reported Q4 2025 revenue of $7 million, a 72.6% sequential rise driven primarily by product shipments, and closed the year with $27.2 million in total revenue (about $20 million on an adjusted basis). Gross margin was 37.7% (about 43% excluding inventory...
Progyny Inc (PGNY) Q4 2025 Earnings Call Transcript
Progyny reported record fiscal 2025 revenue of $1.29 billion, a 10% increase year‑over‑year, and adjusted EBITDA of $222 million, both surpassing guidance midpoints. Operating cash flow rose 17% to $210 million, while gross margin improved by nearly 200 basis points due to care‑management...
United Parks & Resorts Inc (PRKS) Q4 2025 Earnings Call Transcript
SeaWorld Entertainment reported Q3 2021 revenue of $521.2 million, a 10% increase year‑over‑year, driven by a 23.7% rise in revenue per capita despite a 1% attendance dip excluding international and group guests. Adjusted EBITDA hit a record $265.3 million, up 28%, while...
Morgan Stanley Direct Lending Fund (MSDL) Q4 2025 Earnings Call Transcript
Morgan Stanley delivered record 2025 results, posting $70.6 billion in total revenue and a historic $10.21 earnings per share. Total client assets rose to $9.3 trillion, while wealth management generated $31.8 billion in revenue and attracted $356 billion of net new assets. The firm’s...
OrthoPediatrics Corp (KIDS) Q4 2025 Earnings Call Transcript
PolyPid announced successful completion of the Phase III SHIELD II trial, with D‑PLEX100 achieving its primary and key secondary endpoints and demonstrating a meaningful reduction in surgical site infections. The FDA provided written support for a rolling NDA review, and the company...
Delcath Systems Inc (DCTH) Q4 2025 Earnings Call Transcript
Delcath Systems reported record 2025 revenue of $85.2 million, driven by over 40% volume growth and 28 REMS‑certified treatment centers. Gross margins held at 85% for Q4 and 86% for the full year, while adjusted EBITDA turned positive to $25.1 million and...
Nexstar Media Group Inc (NXST) Q4 2025 Earnings Call Transcript
News Corp reported Q4 2025 revenue of $2.4 billion, a 6% year‑over‑year increase, and total segment EBITDA of $521 million, up 9% despite a $16 million one‑time charge at HarperCollins. Adjusted earnings per share rose to $0.40 and profitability margin improved to 22.1%,...
PRA Group Inc (PRAA) Q4 2025 Earnings Call Transcript
PRA Group reported record financial results for 2025, with estimated remaining collections (ERC) reaching $8.6 billion, cash collections $2.1 billion and revenue $1.2 billion, all new highs. Portfolio purchases totaled $1.2 billion, matching its target and driving higher purchase‑price multiples in both the U.S....
Anika Therapeutics Inc (ANIK) Q4 2025 Earnings Call Transcript
Anika Therapeutics reported total revenue of $27.8 million for the quarter, a 6% year‑over‑year decline driven primarily by lower pricing in its OEM osteoarthritis pain‑management channel. Commercial channel revenue rose 22% to $12 million, powered by a 25% surge in...
Personalis Inc (PSNL) Q4 2025 Earnings Call Transcript
Personalis reported a record $18.2 million Q4 2019 revenue, a 38% year‑over‑year increase, and full‑year revenue of $65.2 million, up 73% from 2018. The VA Million Veteran Program (MVP) remained the core revenue driver, contributing $43.5 million for the year and $13.8 million in...
EMCOR Group Inc (EME) Q4 2025 Earnings Call Transcript
EMCOR Group reported record third‑quarter revenue of $4.3 billion, up 16.4% year‑over‑year, and diluted EPS of $6.57, a 13.3% increase. Operating margin reached 9.4%, at the top of management’s range, while remaining performance obligations hit a record $12.6 billion, 29% higher than...
Ligand Pharmaceuticals Inc (LGND) Q4 2025 Earnings Call Transcript
Ligand Pharmaceuticals reported a breakout 2025, delivering $268 million total GAAP revenue and $240 million core revenue, driven by a 48% surge in royalty income. Adjusted earnings per share rose 42% to $8.13, surpassing guidance by more than 30%, while cash and...
TriMas Corp (TRS) Q4 2025 Earnings Call Transcript
TriMas Corp reported third‑quarter 2025 net sales of $269 million, a 17% year‑over‑year increase driven by 16% organic growth and strong aerospace performance. Operating profit rose 34% to $30.3 million and adjusted EBITDA climbed 25% to $48 million, while adjusted EPS jumped 42%...
Xponential Fitness Inc (XPOF) Q4 2025 Earnings Call Transcript
Xponential Fitness reported Q3 2025 adjusted EBITDA of $33.5 million, up 9% year‑over‑year, with a margin expanding to 42%. Consolidated revenue slipped 2% to $78.8 million, driven by a 49% plunge in equipment sales and softer merchandise demand. Franchise revenue rose 17%...
Papa John's International Inc (PZZA) Q4 2025 Earnings Call Transcript
Papa John’s reported a 1% drop in global system‑wide sales for Q4 2025, with North America comparable sales falling 5% while international markets rose 6%, led by a 7% gain in the UK. Total revenue slipped 6% to $498 million and...
TopBuild Corp (BLD) Q4 2025 Earnings Call Transcript
TopBuild reported a 5% decline in Q2 2025 sales to $1.3 billion, driven by a low‑double‑digit drop in residential volume while commercial and industrial segments grew. The company highlighted the recent Progressive Roofing acquisition, which adds roughly $215 million of second‑half sales...
MannKind Corp (MNKD) Q4 2025 Earnings Call Transcript
MannKind reported a record Q4 2024 with $77 million in revenue and a full‑year total of $286 million, a 43% increase year‑over‑year. Afrezza sales grew 17% to $64 million, and the company announced a pediatric filing for the inhaled insulin in the first...
Bain Capital Specialty Finance Inc (BCSF) Q4 2025 Earnings Call Transcript
Bain Capital Specialty Finance reported net investment income of $0.45 per share, delivering a 10.3% annualized yield on book value and exceeding its regular dividend by 7%. The board declared a total Q4 dividend of $0.45 per share, translating to...
Standard Motor Products Inc (SMP) Q4 2025 Earnings Call Transcript
Standard Motor Products reported Q4 2019 net sales of $241.3 million, a 2.3% decline year‑over‑year, while full‑year 2019 revenue reached $1.12 billion, up 1.6%. The company highlighted margin improvements in Engine Management, driven by the General Cable integration and cost‑reduction initiatives,...